about
Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valvesNotch1 regulates the fate of cardiac progenitor cellsConserved transcriptional regulatory mechanisms in aortic valve development and diseaseDevelopmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscleHearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development.Differential trans activation associated with the muscle regulatory factors MyoD1, myogenin, and MRF4.Congenital heart disease linked to maternal autoimmunity against cardiac myosin.Twist1 directly regulates genes that promote cell proliferation and migration in developing heart valvesThe molecular genetic revolution in congenital heart disease.Transcriptional regulation of heart valve development and disease.Genome-wide Twist1 occupancy in endocardial cushion cells, embryonic limb buds, and peripheral nerve sheath tumor cells.Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cellsWherefore heart thou? Embryonic origins of cardiogenic mesoderm.FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress.Notch pathway regulation of neural crest cell development in vivo.Cardiac fibroblasts: from development to heart failure.T-box genes and heart development: putting the "T" in heart.Placement of an elastic biodegradable cardiac patch on a subacute infarcted heart leads to cellularization with early developmental cardiomyocyte characteristicsPod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart.Ras-related signaling pathways in valve development: ebb and flow.GENE EXPRESSION AND COLLAGEN FIBER MICROMECHANICAL INTERACTIONS OF THE SEMILUNAR HEART VALVE INTERSTITIAL CELL.Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction.Cardiac Fibrosis: The Fibroblast AwakensPrinciples of genetic murine models for cardiac disease.Shared gene expression profiles in developing heart valves and osteoblast progenitor cellsBone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.COX2 inhibition reduces aortic valve calcification in vivoNotch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development.Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease.Heart valve development: regulatory networks in development and diseaseFoxO transcription factors promote autophagy in cardiomyocytesTranscriptional regulation of heart valve progenitor cells.Notch signaling and the developing skeleton.Novel cell lines promote the discovery of genes involved in early heart development.Epicardium-derived fibroblasts in heart development and disease.Developmental Mechanisms of Aortic Valve Malformation and Disease.Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development.Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
P50
Q24298082-3C59DD32-E92D-4075-A877-64C36160E573Q24656564-1199B791-62DA-4C6A-A942-1B044817C10DQ24656564-89C45505-42E3-4D46-B90C-62D82FCB4C97Q27014023-CE541088-0CB4-4F32-8627-AEA03727315FQ28508516-F8E9FF67-B59F-4F78-96F6-C3FF16B15956Q30354085-96EDE084-FAC2-4A3A-90D4-66042D33AE63Q30356643-527B2A70-9CBA-43DF-B462-9721A3E3EDFCQ34035986-863CDCDE-72C3-40CA-8705-5F06717362D3Q34126540-8B8B9FD7-C006-4ADA-BAD2-588E5414CCCEQ34164407-A56E3395-E9FF-454D-9AD6-CC961B31DC07Q34307567-A4E75578-3480-4B21-A2A0-8A83D40504B4Q34308984-2C75E281-82AD-4F6E-A101-B14AC4B25B3EQ34353340-266A4F90-7A43-45B2-8466-B23186722C9FQ34421680-E7C4E09C-0D8A-4DA0-ABA4-C9ACE5BDF298Q34550461-BBCB9EB7-FB73-446C-88FC-C4ED96913751Q34561583-DE3B4F4F-5ECE-4E65-BF29-AE9051BF8E76Q34606366-10127AEE-3BF6-4EA8-A238-4EE5459BD095Q35698022-1329FA97-6F86-4239-81AA-A7B4115001D0Q35883291-BE12426A-EA6B-4CB9-A4C2-B43DB05F2E56Q35973547-9A6372D9-692F-4A72-98FC-975FDF920351Q36108819-6105E7BA-56A0-4BD6-8742-8D3195577511Q36148533-C5E602A0-A876-4502-98C3-3A1FD4F7ADEDQ36313076-1A185F31-101E-44C3-84EE-EC6D3C734E29Q36399850-34E340B8-ED53-4DEA-854A-C6F9F54112BBQ36689735-626F38EB-151F-4C7A-AFE9-4423029D37B1Q36708340-1A4EA39B-7A8F-4ED3-A10E-769F4F2E76F0Q36734527-50711806-43E9-4A6A-B74E-3F7FCEF89B0BQ36877544-3EA9C8BB-082E-479E-85DB-3BC3D1EC9926Q37033822-B9EE57C5-72E3-4575-BA86-2437BD59E10AQ37164445-1B1B18F2-8FBA-4698-B90B-B52605F7CAAFQ37321215-F1B5C156-2C01-49CF-AF49-396EA47901CFQ37359133-C070FF92-5013-447F-8FD4-CDD0BCDA6230Q37421779-82FA0506-BD0B-4920-A432-DF6BDF609D7CQ37459990-9613B144-3A59-459E-9055-DEE6C87C7D3EQ37663819-55BB8BE4-217B-44FD-9FD3-D852A7493946Q37991576-A544BD8E-4C23-42F5-BAF7-026626A55710Q38299308-EB729FC7-B6DD-4D52-92E9-B323C65F098EQ38603614-9FBD33B4-E05A-442B-A59D-D685FA2F3773Q38783495-15911AFC-5E86-42CD-9191-A6BC79922C0BQ38847587-B3019465-D08C-4FE9-AC4C-4D8F961AD0F5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katherine E. Yutzey
@ast
Katherine E. Yutzey
@en
Katherine E. Yutzey
@es
Katherine E. Yutzey
@nl
Katherine E. Yutzey
@sl
type
label
Katherine E. Yutzey
@ast
Katherine E. Yutzey
@en
Katherine E. Yutzey
@es
Katherine E. Yutzey
@nl
Katherine E. Yutzey
@sl
prefLabel
Katherine E. Yutzey
@ast
Katherine E. Yutzey
@en
Katherine E. Yutzey
@es
Katherine E. Yutzey
@nl
Katherine E. Yutzey
@sl
P106
P1153
7003710523
P21
P31
P496
0000-0002-1444-7124